P18.01 The Neuro-Oncology Branch Patient Outcomes Program (POP)

Por Armstrong, T. S., Gilbert, M. R.
Publicado no Neuro Oncol (2017)

P15.01 WOUND HEALING COMPLICATIONS IN BRAIN TUMOR PATIENTS ON BEVACIZUMAB

Por Ladha, H., Pawar, T., Gilbert, M.R., Armstrong, T.S.
Publicado em 2014

Phase I–II clinical trial design: a state-of-the-art paradigm for dose finding

Por Yan, F, Thall, P F, Lu, K H, Gilbert, M R, Yuan, Y
Publicado no Ann Oncol (2018)

O8.10 A MODEL FOR RESEARCH INITIATIVES FOR RARE CANCERS: THE COLLABORATIVE EPENDYMOMA RESEARCH NETWORK (CERN)

Por Armstrong, T.S., Aldape, K., Gajjar, A., Haynes, C., Hirakawa, D., Gilbertson, R., Gilbert, M.R.
Publicado em 2014

OS05.6 Final risk model for Temozolomide (TMZ)-Myelotoxicity in patients with Glioblastoma treated on NRG Oncology’s RTOG 0825

Por Armstrong, T. S., Gilbert, M. R., Bondy, M., Sulman, E., Yuan, Y., Zhou, R., Vera, E., Wendland, M., Pugh, S., Scheurer, M.
Publicado no Neuro Oncol (2017)

O6.01 TARGETING THE IMMUNE CHECKPOINT NETWORK WITH MIR-138 EXERTS THERAPEUTIC EFFICACY IN MURINE MODELS OF GLIOMA

Por Heimberger, A., Wei, J., Nduom, E., Kong, L., Ivan, C., Fuller, G.N., Gilbert, M.R., Conrad, C.A., Calin, G.A.
Publicado em 2014

Two phase II trials of temozolomide with interferon-α2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme

Por Groves, M D, Puduvalli, V K, Gilbert, M R, Levin, V A, Conrad, C A, Liu, V H, Hunter, K, Meyers, C, Hess, K R, Alfred Yung, W K
Publicado em 2009

Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma

Por de Groot, J. F., Gilbert, M. R., Aldape, K., Hess, K. R., Hanna, T. A., Ictech, S., Groves, M. D., Conrad, C., Colman, H., Puduvalli, V. K., Levin, V., Yung, W. K. A.
Publicado no J Neurooncol (2008)

A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients

Por Raizer, J. J., Giglio, P., Hu, J., Groves, M., Merrell, R., Conrad, C., Phuphanich, S., Puduvalli, V. K., Loghin, M., Paleologos, N., Yuan, Y., Liu, D., Rademaker, A., Yung, W. K., Vaillant, B., Rudnick, J., Chamberlain, M., Vick, N., Grimm, S., Tremont-Lukats, I. W., De Groot, J., Aldape, K., Gilbert, M. R.
Publicado no J Neurooncol (2016)